Okano, Hiromu
Yamamoto, Ryohei http://orcid.org/0000-0002-5144-6585
Iwasaki, Yudai
Irimada, Daisuke
Konno, Daisuke
Tanaka, Taku
Oishi, Takatoshi
Nawa, Hiroki
Yano, Akihiko
Taniguchi, Hiroaki
Otawara, Masayuki
Matsuoka, Ayaka
Yamauchi, Masanori
Clinical trials referenced in this document:
Documents that mention this clinical trial
External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan
https://doi.org/10.1186/s40560-024-00720-8
Article History
Received: 8 November 2023
Accepted: 7 February 2024
First Online: 15 February 2024
Declarations
:
: The Institutional Review Board of Tohoku University (2022-I-265) and that of each center reviewed and approved the study. The requirement for informed consent from all participants enrolled in this study was waived by the committee because of the retrospective study design.
: Not applicable.
: The authors declare that they have no competing interests.